Figure 2.
Response of PFC endocannabinoid levels and FAAH activity following intracerebroventricular CRH. A–C, Effects of intracerebroventricular vehicle or 1 μg CRH infusions 10 min after administration on (A) AEA, (B) FAAH hydrolytic activity, (C) 2-AG. D–F, Effects of intracerebroventricular vehicle or 1 μg CRH infusions 30 min after administration on (D) AEA, (E) FAAH hydrolytic activity, (F) 2-AG. G–I, Effects of intracerebroventricular vehicle or 1 μg CRH infusions 120 min after administration on (G) AEA, (H) FAAH hydrolytic activity, (I) 2-AG. Data are mean + SEM; n = 6–8/group for AEA and 2-AG levels; n = 4/group for FAAH hydrolytic activity. *p < 0.05.